Kimura, Tanaka et al. perform exome and RNA sequencing in Japanese melanoma patients to investigate genomic and transcriptomic factors associated with clinical efficacy of immune checkpoint inhibitors. Findings reveal the characteristic genomic features and potential biomarkers of melanoma in Japanese patients.
- T. Kimura
- N. Tanaka
- S. Fukushima
